Amyloid- peptide (A) is the amyloid component of senile plaques in Alzheimer disease (AD) brains. Recently a soluble oliomeric form of A in A precursor protein transgenic mouse brains and AD brains was identified as a potential causative molecule for memory impairment, suggesting that soluble A oligomers cause neurodegeneration in AD. Further characterization of this species has been hampered, however, because the concentrations are quite small and it is difficult to monitor A oligomers specifically. Here we developed a novel method for monitoring A oligomers using a split-luciferase complementation assay. In this assay, the Nand C-terminal fragments of Gaussia luciferase (Gluc) are fused separately to A. We found that conditioned media from both N-and C-terminal fragments of Gluc-tagged A1-42 doubly transfected HEK293 cells showed strong luminescence. We used gel filtration analyses to analyze the size of oligomers formed by the luciferase complementation assay, and found that it matched closely with oligomers formed by endogenous A in Tg2576 neurons. Large oligomers (24 -36-mers), 8-mers, trimers, and dimers predominate. In both systems, A formed oligomers intracellularly, which then appear to be secreted as oligomers. We then evaluated several factors that might impact oligomer formation. The level of oligomerization of A1-40 was similar to that of A1-42. Homodimers formed more readily than heterodimers. The level of oligomerization of murine A1-42 was similar to that of human A1-42. As expected, the familial AD-linked Arctic mutation (E22G) significantly enhanced oligomer formation. These data suggest that Gluc-tagged A enables the analysis of A oligomers.
Alzheimer disease (AD)2 is common progressive neurodegenerative disorder causing dementia. In AD patient's brains, loss of neocortical synapses correlates with cognitive impairment (1). A is the amyloid component of senile plaques in AD brains (2, 3) and is derived from the A precursor protein (APP) through sequential proteolytic cleavage by -secretase and ␥-secretase (4). Based on several genetic and biochemical studies, the amyloid hypothesis is now widely accepted as the pathogenesis of AD (4). It has recently been suggested that picomolar concentrations of dimeric, or oligomeric, rather than monomeric or fibrillar forms of A, are the most neurotoxic, but characterization of these forms of soluble A is technically difficult.In previous in vitro A fibrillization studies using synthetic A, a variety of soluble prefibrillar species, including A protofibrils (5, 6), A-derived diffusible ligands (7), and amylospheroids (8) were reported as neuronal toxic molecules. Recently, soluble A oligomers, A*56 (9) and A dimers (10) were isolated from APP transgenic mouse brain and AD brain and these A oligomers caused synaptic dysfunction and memory impairment. Moreover A oligomers were observed to associate with senile plaques and correlate with synaptic loss in AD brains (11). These data suggest that prefibrillar A oligomers may be a ...